Medtronic Anticipates More Severe Declines in Coming Months
The company’s orthopedic revenues for its fiscal fourth quarter fell -35% as it endured an additional month of COVID-related impact in April compared to competitors. May 26, 2020
Seikagaku Grows in FY19 on Strength in U.S. Market
The company grew in FY19 despite COVID-related declines in its fourth quarter, driven by both reimbursement wins and competitive account conversions. May 21, 2020
Orthopedics to Take Unprecedented Hit from COVID-19, Market Fundamentals Remain Strong
The underlying fundamentals of the orthopedic industry remain unchanged due to COVID-19. However, we should prepare for significant alterations in the market landscape as well as the ways that we interact with colleagues and customers. May 19, 2020
SeaSpine to Pursue Aggressive Launch Cadence Despite COVID-19
The company was able to offset deeper COVID-related declines on the strength of its advanced DBM portfolio and plans to pursue several alpha launches of new products in 2020. May 14, 2020
Conformis Gets Battered by COVID-19 Procedure Deferrals
Geographic factors and a highly elective portfolio exposed the company to a severe downturn due to COVID-19, with 1Q20 revenue down 20% and April revenues down 95%. May 14, 2020
Zimmer Biomet Doubling Down on Innovation During COVID
While the company’s orthopedic revenues declined in the high single-digits in 1Q20, Zimmer Biomet’s balance sheet and cost containment measures will allow it to aggressively pursue key R&D initiatives. May 13, 2020
Integra LifeSciences Anticipates Market Recovery in 4Q20
The company’s orthopedic business declined in mid-single digits for 1Q20, with a precipitous -80% decline in April. However, Integra expects the market to right itself by year-end. May 13, 2020
Orthofix Procedure Volume Down -60% in April Due to COVID-19
The company’s sales declined in the mid-single digits in 1Q20, but included a few bright spots like continuing adoption of the M6-C artificial disc. May 12, 2020
ATEC Spine Bullish on Growth Prospects Despite COVID
The company’s late-2019 growth momentum continued for most of 1Q20, resulting in nearly 22.6% growth. ATEC is confident the spine market will be one of the first to rebound from COVID-19. May 12, 2020
DJO’s Share-Taking Momentum Undercut by COVID-19
The company was on pace to deliver double-digit growth in 1Q20 before COVID-related surgical delays, and procedures were down roughly 90% in April. May 12, 2020
